Incidence of Blood Clots in Adults Tested for SARS-CoV-2

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, APRIL 5, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0488?guestAccessKey=e8620d24-f35f-4089-9f59-36ca7d2db35f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040521

 

What The Study Did: The 30-day incidence of outpatient and hospital-associated blood clots following SARS-CoV-2 testing among adults in a large health system was examined in this study.

Authors: Nareg H. Roubinian, M.D., of Kaiser Permanente Northern California in Oakland, is the corresponding author.

 

(doi:10.1001/jamainternmed.2021.0488)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.